Le Lézard9d
Update on regulatory review of lecanemab for treatment of early Alzheimer's disease in the European Union
BioArctic AB's (publ) partner Eisai today announced that the European Commission has asked the Committee for Medicinal Products for Human Use (CHMP) to consider two additional questions. These ...
Bristol Myers gets positive CHMP opinion for Opdivo plus Yervoy
Squibb announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended ...
Merck’s capvaxive receives positive EU CHMP opinion for pneumococcal vaccine
Merck (MRK) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, recommended ...
Finanznachrichten9d
BioArctic: Update on regulatory review of lecanemab for treatment of early Alzheimer's disease in the European Union
In November 2024, a positive opinion was received from the Committee for Medicinal Products for Human Use (CHMP ... Several of the projects utilize the company's proprietary BrainTransporter ...
Bristol Myers Gets CHMP Backing for Expanded Breyanzi, Opdivo/Yervoy Uses
Bristol Myers on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Breyanzi for the treatment of adults with relapsed or refractory ...
Le Lézard10d
Update on Regulatory Review of Lecanemab for Early Alzheimer's Disease in the European Union
In November 2024, a positive opinion was received from the Committee for Medicinal Products for Human Use (CHMP ... intellectual property and other proprietary rights and uncertainties relating to ...
AstraZeneca's Imfinzi on track for EU approval in LS-SCLC treatment
AstraZeneca PLC (LSE/STO/NASDAQ:LON:AZN), a pharmaceutical giant with a market capitalization of $215.44 billion and impressive gross profit margins of 82.61%, has received a recommendation for ...
Zacks.com on MSN6d
MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive
Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of its 21-valent pneumococcal conjugate ...
Daily15d
Sanofi Sarclisa approved in EU for newly diagnosed multiple myeloma
Paris: Following the adoption of a positive opinion by the European Medicines Agency's (EMA) Committee for Medicinal Products ...
centerforbiosimilars3d
CHMP Pushes 3 Biosimilars Forward, Spelling Hope for Ophthalmology, Supportive Care Markets
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...
EuropaWire5d
AstraZeneca’s Imfinzi Recommended for EU Approval as Breakthrough Treatment for Limited-Stage Small Cell Lung Cancer
AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...
PharmiWeb28d
Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma
In the US, the non-proprietary name for Sarclisa is isatuximab-irfc ... On November 14, 2024, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) adopted a ...